Please use this identifier to cite or link to this item: http://www.alice.cnptia.embrapa.br/alice/handle/doc/948750
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGASPAR, E. B.
dc.contributor.authorSANTOS, L. R. dos
dc.contributor.authorARAUJO, F. R.
dc.contributor.authorGULIAS-GOMES, C. C.
dc.contributor.authorLINCOPAN, N.
dc.contributor.authorBRANDAO, H. de M.
dc.contributor.authorROSINHA, G. M. S.
dc.date.accessioned2025-06-25T15:47:47Z-
dc.date.available2025-06-25T15:47:47Z-
dc.date.created2013-02-07
dc.date.issued2012
dc.identifier.citationIn: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012.
dc.identifier.urihttp://www.alice.cnptia.embrapa.br/alice/handle/doc/948750-
dc.descriptionThis project aims the development of a new vaccine against babesiosis and anaplasmosis based on a chimeric protein and new adjuvants. A chimeric protein formed by Anaplasma marginale VirB9 and Virb10 protein and B. bigemina PO protein will be constructed by genetic engineering.
dc.language.isoeng
dc.rightsopenAccess
dc.titleDevelopment of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale associated with nanoparticles adjuvants.
dc.typeResumo em anais e proceedings
dc.subject.thesagroAnaplasmose
dc.subject.thesagroBabesiose
dc.subject.thesagroVacina
dc.format.extent2p. 153.
riaa.ainfo.id948750
riaa.ainfo.lastupdate2025-06-25
dc.contributor.institutionEMANUELLE BALDO GASPAR, CPPSUL; LENITA RAMIRES DOS SANTOS, CNPGC; FLABIO RIBEIRO ARAUJO, CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; N. LINCOPAN, USP; HUMBERTO DE MELLO BRANDAO, CNPGL; GRACIA MARIA SOARES ROSINHA, CNPGC.
Appears in Collections:Resumo em anais de congresso (CNPGL)

Files in This Item:
File Description SizeFormat 
Development-of-recombinant-vaccine.pdf377.57 kBAdobe PDFThumbnail
View/Open
Show simple item record

FacebookTwitterDeliciousLinkedInGoogle BookmarksMySpace